Compositions and methods of treating dry eye syndrome and other traumatized non-keratinized epithelial surfaces
AssigneeEye Care International, LLC
InventorsMatthew B. Dowling, Steven E. Lazar, Helga M. Gentile
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a composition including non-autologous plasma or serum and a polymer; method of treating ophthalmic diseases (e.g., dry eye syndrome) or moisturizing and/or repairing non-keratinized surfaces including non-healing wounds with a composition including non-autologous plasma or serum and a polymer; and a therapeutic agent delivery device for delivery of the composition to the eye or a non-keratinized surface of a subject.
Claims15
A pharmaceutical composition comprising serum and a polysaccharide or derivative thereof having a molecular weight of 100 to 1200 kDA in an aqueous carrier, wherein the composition comprises 50-90 weight percent (wt %) serum and 0.025% to 2.0% polysaccharide, and wherein the polysaccharide is hydrophobically modified chitosan.
Dependencies are inferred from the claim text.